Cargando…

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models

Gallbladder cancer is a highly aggressive malignancy with poor sensitivity to postoperative radiotherapy or chemotherapy; therefore, the development of individualized treatment strategies is paramount to improve patient outcomes. Both patient-derived tumor xenograft (PDX) and patient-derived tumor o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Dengxu, An, Jiaze, Gong, Miaomiao, Wang, Huihui, Li, Han, Meng, Han, Zhang, Caiqin, Zhao, Yong, Ge, Xu, Shi, Changhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795198/ https://www.ncbi.nlm.nih.gov/pubmed/36591461 http://dx.doi.org/10.3389/fonc.2022.1043479

Ejemplares similares

Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy
por: Gong, Miaomiao, et al.
Publicado: (2023)

The Application of [(68)Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models
por: Zhang, He, et al.
Publicado: (2022)

Application of Organoid Models in Prostate Cancer Research
por: Zhou, Ligui, et al.
Publicado: (2021)

Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine
por: Zhang, He, et al.
Publicado: (2022)

The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma
por: Zhang, Caiqin, et al.
Publicado: (2017)

Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation
por: Wu, Pengpeng, et al.
Publicado: (2020)

Patient-derived bladder cancer xenograft models reveal VEGF and CDK4 enhancing tumor metastasis behavior
por: Zhao, Yong, et al.
Publicado: (2019)

NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye
por: Zhang, Caiqin, et al.
Publicado: (2018)

Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma
por: An, Jiaze, et al.
Publicado: (2017)

Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy
por: Guo, Wenwen, et al.
Publicado: (2021)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

A deep learning model for drug screening and evaluation in bladder cancer organoids
por: Zhang, Shudi, et al.
Publicado: (2023)

Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma
por: Yang, Changhong, et al.
Publicado: (2021)

Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
por: Yuan, Bo, et al.
Publicado: (2022)

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
por: Xie, Cuiying, et al.
Publicado: (2023)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma
por: Wang, Jinghan, et al.
Publicado: (2020)

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy
por: Yang, Ziyi, et al.
Publicado: (2022)

Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
por: Gamboa, Christian Moya, et al.
Publicado: (2021)

Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization
por: Lucky, Sasidharan Swarnalatha, et al.
Publicado: (2021)

Xenograft and organoid model systems in cancer research
por: Bleijs, Margit, et al.
Publicado: (2019)

Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures
por: Wakamatsu, Toru, et al.
Publicado: (2022)

The applications and techniques of organoids in head and neck cancer therapy
por: Qi, Hao, et al.
Publicado: (2023)

Anion Transport Across Human Gallbladder Organoids and Monolayers
por: Zarei, Keyan, et al.
Publicado: (2022)

Development and Validation of a Preoperative Nomogram for Predicting Benign and Malignant Gallbladder Polypoid Lesions
por: Han, Shuai, et al.
Publicado: (2022)

Patient-derived organoids facilitating individual therapy in an adolescent with embryonal rhabdomyosarcoma of the cervix: a case report and literature review
por: Qiao, Xinyu, et al.
Publicado: (2023)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023)

Progress in gallbladder cancer with lymph node metastasis
por: Li, Yuhang, et al.
Publicado: (2022)

Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes
por: Zhao, Ningning, et al.
Publicado: (2016)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination
por: Wang, Zeyu, et al.
Publicado: (2022)

A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma
por: Zhao, Chenglong, et al.
Publicado: (2022)

Expression and Clinical Implications of Cysteine Cathepsins in Gallbladder Carcinoma
por: Mehra, Siddharth, et al.
Publicado: (2019)

Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder
por: Zou, Rui-Qi, et al.
Publicado: (2022)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
por: Esser, Laura K., et al.
Publicado: (2020)

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma
por: Yang, Yonghao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b4j452rf0k535ijrt7jpimpfum